...Kamila Kolanska; Merwane Roche; Camille Carrière; Marjolaine Le Gac; Nathalie Ferrand; Maurice Zaoui; Morgane Le Gall; Lise Selleret; Joseph Gligorov; Michèle Sabbah; Selim Aractingi; Nathalie Chabbert-Buffet Introduction: Fetal microchimerism could be involved in the regulation of breast cancer...

... phenomena in development and disease. Epithelial-mesenchymal transition TEMTIA Breast cancer Neural crest Implantation © 2021 S. Karger AG, Basel 2021 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages...

...Tressa M. Allington; William P. Schiemann Transforming growth factor-β (TGF-β) normally inhibits breast cancer development by preventing mammary epithelial cell (MEC) proliferation, by inducing MEC apoptosis, and by creating cell microenvironments that maintain MEC homeostasis and prevent...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer Epithelial-mesenchymal transition E-cadherin transcriptional repression Inter-regulation Epithelial-mesenchymal transition (EMT) is a complex...

...Celina G. Kleer; Yanhong Zhang; Sofia D. Merajver CCN6 (WISP3) is a cysteine-rich secreted protein that belongs to the CCN (Cyr61, CTGF, Nov) family of genes. We found that CCN6 mRNA is reduced in 80% of cases of the most lethal form of locally advanced breast cancer, inflammatory breast cancer...

...Maria I. Kokkinos; Razan Wafai; Meng Kang Wong; Donald F. Newgreen; Erik W. Thompson; Mark Waltham Breast cancer is a highly prevalent disease among women worldwide. While the expression of certain proteins within these tumours is used for prognosis and selection of therapies, there is a continuing...